Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-15-006923)

Filing Details

Accession Number:: 0000899243-15-006923
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-10-20 20:00:27
Reporting Period:: 2015-09-14

Filing Date:: 2015-10-20
Accepted Time:: 2015-10-20 20:00:27
Original Submission Date:: 2015-09-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374690	Zafgen Inc.	ZFGN	Pharmaceutical Preparations (2834)	203857670

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1456750	D Dennis Kim	C/O Zafgen, Inc. 175 Portland Street, 4Th Floor Boston MA 02114	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-14	593	$40.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed to disclose that the sale of these shares reported in the original Form 4 by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.